Comparison

ATR-IN-4 European Partner

Manufacturer MedChem Express
Category
Type Inhibitors
Specific against other
Amount 25 mg
Item no. HY-145312-25mg
Targets ATR, ATM
CASRN 2574545-45-0
eClass 6.1 30220300
eClass 9.0 32160605
Available
Product Description
ATR-IN-4 is a potent ATR (Ataxia telangiectasia mutated gene Rad 3-associated kinase) inhibitor. ATR-IN-4 inhibits growth of human prostate cancer cells DU145 and human lung cancer cells NCI-H460 with IC50s of 130.9 nM and 41 .33 nM, respectively. (Patent CN112142744A, compound 13)[1].
StorageTemperature
4°C (Powder, sealed storage, away from moisture and light)
Shipping
Room Temperature
Manufacturers Applications
Cancer-Kinase/protease
Molecular Weight
364.40
Clinical Information
No Development Reported
Solubility
DMSO : 25 mg/mL (ultrasonic)
Pathway
Cell Cycle/DNA Damage; PI3K/Akt/mTOR
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 25 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close